BioCircuit Technologies
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Georgia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1819 Peachtree Rd NE Ste 350, Atlanta, G...Phone Number
(800) 905-2204Website
www.biocircuit.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About BioCircuit Technologies
BioCircuit Technologies specializes in the development and commercialization of advanced medical devices focused on tissue repair and neuromodulation. Their flagship product, Nerve Tape®, is the first FDA-cleared sutureless device designed for repairing transected nerves, enhancing surgical efficiency and reducing tissue damage. The company aims to empower clinicians with innovative tools that improve the diagnosis and treatment of nerve injuries across various medical specialties. BioCircuit Technologies serves healthcare professionals, particularly in plastic and reconstructive surgery, by providing solutions that streamline nerve repair procedures.Explore more
BioCircuit Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioCircuit Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
BioCircuit Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on BioCircuit Technologies recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at BioCircuit Technologies
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if BioCircuit Technologies has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if BioCircuit Technologies is spiking on competitors!
Product Launch: Get notified when BioCircuit Technologies launches new products
Funding: Get notified immidiatlly once BioCircuit Technologies has new funding data
Click to see if BioCircuit Technologies had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to BioCircuit Technologies
Compare insights from companies similar to BioCircuit Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BioCircuit Technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BioCircuit Technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioCircuit Technologies.
BioCircuit Technologies financials insights
Gather financial insights about BioCircuit Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$9M
BioCircuit Technologies Tech Stack
A closer look at the technologies used by BioCircuit Technologies
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Award
Award, Finance
Facilities Relocation / Expansion
BioCircuit Technologies is planning to move offices in October 2025. The move will impact approximately 30 employees at the existing office located at 1819 Peachtree Rd, Suite #205, Atlanta, GA.
Facilities Relocation/Expansion
Executive Move
Executive Moves, Board of Directors
Funding
Project
Spending/Investment, Clinical Operations, Operations
BioCircuit Technologies News & Media
NIH Awards BioCircuit Technologies $3M to Expand Nerve Tape®
Funding will extend the Nerve Tape product line and accelerate clinical adoption. ATLANTA, Nov. 20, 2024 /PRNewswire-PRWeb/ -- Medical device company BioCircuit Technologies has received a prestigious funding award towards further development of Nerve Tape®, the first device for...BioCircuit Technologies Announces First Human Implants of Nerve Tape®
Surgeons across the US are now using Nerve Tape to achieve sutureless nerve repair ATLANTA, June 6, 2024 /PRNewswire-PRWeb/ -- BioCircuit Technologies®, a leader in medical device innovation, is proud to announce the first human implantations of Nerve Tape, the first FDA-approved device...BioCircuit Technologies closes $9m financing round - Med-Tech Innovation
BioCircuit Technologies, a medical device company focused on peripheral nerve repair and neuromodulation, has closed a $9 million round of financing.BioCircuit Technologies, Inc. Closes a $9 million Series Seed Round
Nerve Tape® Sutureless solution for surgical repair of transected nerves Atlanta, GA, Sept. 27, 2022 (GLOBE NEWSWIRE) -- BioCircuit Technologies®, a medical device company focused on peripheral nerve repair and neuromodulation, announces the close of a $9 million round of financing. Mike Masters of Masters Capital, the GRA Venture Fund and Alsora Capital continued their support, alongside existing shareholders. “We are very grateful to our investors for the support they have shown and continue t
Read more news
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding BioCircuit Technologies
Sign Up For FreeTo access detailed company insights
BioCircuit Technologies specializes in the development and commercialization of advanced medical devices focused on tissue repair and neuromodulation. Their flagship product, Nerve Tape®, is the first FDA-cleared sutureless device designed for repairing transected nerves, enhancing surgical efficiency and reducing tissue damage. The company aims to... Read More
